Company / Net Income
Pacira BioSciences, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$7.0M
FY2025
5-year range
-$99.6M / $42.0M
FY2021-FY2025
Trend
+107.1%
vs FY2024
Sector context
#59 of 216
Health Care
What the data says
At $7M, Pacira BioSciences, Inc.'s net income ranks #59 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$100M in FY2024 to $42M in FY2023.
Based on SEC 10-K filings.
$7M in FY2025 with a 3-year CAGR of -23.8%.
Declined from $42M to $7M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -23.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#59 of 216 in Health CareTop 27% of 216This company $7.0M Sector average $454.1M
▼
-98.5% below sector average
Key checks
Key Insights
- 3-year CAGR of -23.8%, indicating a declining trend.
- In FY2025, net income increased 107.1% year-over-year.
- Ranks #59 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.0M | +107.1% |
| FY2024 | -$99.6M | -337.3% |
| FY2023 | $42.0M | +163.7% |
| FY2022 | $15.9M | +244.4% |
| FY2021 | -$11.0M | -2238.9% |
| FY2020 | -$471.0K | +98.9% |
| FY2019 | -$42.6M | -12.3% |
| FY2018 | -$37.9M | -2144.7% |
| FY2017 | $1.9M | +104.9% |
| FY2016 | -$37.9M | -2144.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026